Patients With T2D Treated With Sulfonylureas May Face Higher Risk Of Contracting TB Compared With Patients Treated With Metformin

Metformin has recently been shown to enhance the immune response to other intracellular pathogens as well. https://www.pulmonologyadvisor.com/tuberculosis/tuberculosis-risk-in-diabetes-treatments/article/737965/